M&A Activity • Jun 11, 2025
M&A Activity
Open in ViewerOpens in native device viewer

| Informazione Regolamentata n. 1795-44-2025 |
Data/Ora Inizio Diffusione 11 Giugno 2025 11:28:22 |
Euronext Milan | |
|---|---|---|---|
| Societa' | : | BANCA MEDIOLANUM | |
| Identificativo Informazione Regolamentata |
: | 206829 | |
| Utenza - referente | : | BCAMEDIOLANUMN07 - Lietti Angelo - 7LVZJ6XRIE7VNZ4UBX81 |
|
| Tipologia | : | 2.2 | |
| Data/Ora Ricezione | : | 11 Giugno 2025 11:28:22 | |
| Data/Ora Inizio Diffusione | : | 11 Giugno 2025 11:28:21 | |
| Oggetto | : | Delibere del CdA di Banca Mediolanum e Mediolanum Vita su OPS di Mediobanca su Banca Generali nell'Assemblea Mediobanca - (Versione Inglese) |
Testo del comunicato
Vedere allegato (Versione Inglese)

PRESS RELEASE
The Boards of Directors of Banca Mediolanum S.p.A. and Mediolanum Vita S.p.A. – both parties to the Shareholders' Consultation Agreement of Mediobanca S.p.A. stipulated pursuant to Article 122 of the Consolidated Law on Finance (TUF) - met today to resolve on the vote to be cast at the Ordinary Shareholders' Meeting of Mediobanca - Banca di Credito Finanziario S.p.A., convened for June 16, 2025 pursuant to Article 104, paragraph 1, of the Consolidated Law on Finance, to approve Mediobanca's voluntary Public Exchange Offer for all ordinary shares of Banca Generali S.p.A. The Board of Directors of Banca Mediolanum and the Board of Directors of Mediolanum Vita resolved to vote in favour of Mediobanca's Public Exchange Offer for Banca Generali at the Mediobanca Shareholders' Meeting, having assessed as positive the business development prospects and financial projections related to the transaction.
Basiglio - Milano 3 City, June 11, 2025
Contatti:
Media & Public Relations Investor Relations Roberto De Agostini Alessandra Lanzone Tel +39 02 9049 2100 Tel +39 02 9049 2039 Mob +39 348 8100 802 Mob +39 335 5684 808
e-mail: [email protected] e-mail: [email protected]
| Numero di Pagine: 3 |
|---|
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.